OPRX (OptimizeRx) Treasury Stock: $-0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPRX OptimizeRx Corp OPRX
59 GF Score
Price $6.53
GF Value $12.89
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is OptimizeRx Treasury Stock?

OptimizeRx OPRX -2.46% 59 Treasury Stock is $-0.0 Mil as of Mar. 2026. GuruFocus rates OPRX with a GF Score™ of 59/100 and a GF Value™ of $12.89 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. OptimizeRx's treasury stock for the quarter that ended in Mar. 2026 was $-0.0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.


OptimizeRx Treasury Stock Historical Data

* Premium members only.

The historical data trend for OptimizeRx's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OptimizeRx Treasury Stock Chart

OptimizeRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 -0.00

OptimizeRx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 -0.00 -0.00 -0.00
OPRX
59GF Score
OptimizeRx Corp OPRX
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OptimizeRx Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $-0.0 Mil mean?
OptimizeRx (OPRX) has a Treasury Stock of $-0.0 Mil as of Mar. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for OptimizeRx and its competitors.
Is OptimizeRx's Treasury Stock too high?
OptimizeRx's current Treasury Stock is $-0.0 Mil. Overall, OptimizeRx has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OptimizeRx's Treasury Stock compare to CCLD and DH?
OptimizeRx's Treasury Stock of $-0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Healthcare Providers & Services company?
A good Treasury Stock depends on the Healthcare Providers & Services industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for OptimizeRx and its competitors. OptimizeRx's current Treasury Stock is $-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptimizeRx stock overvalued right now?
Based on GuruFocus' analysis, OptimizeRx (OPRX) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.89, compared to a current price of $6.53 — trading 49.3% below its estimated fair value. The current Treasury Stock is $-0.0 Mil. OptimizeRx's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For OptimizeRx (OPRX), the current Treasury Stock is $-0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OptimizeRx (OPRX) Overvalued in 2026?

Based on GuruFocus' analysis, OptimizeRx stock appears to be undervalued. The current stock price of $6.53 is trading 49.3% below its estimated GF Value™ of $12.89. GuruFocus considers OptimizeRx to be Significantly Undervalued.

Key valuation signals for OPRX:

  • Treasury Stock: $-0.0 Mil
  • GF Value™: $12.89 vs. price of $6.53 (49.3% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the OPRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OptimizeRx Business Description

Address 260 Charles Street, Suite 302, Waltham, MA, USA, 02453
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
59GF Score

Get the complete analysis for OPRX

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.53
Price
$12.89
GF Value